ProBiotix Health Plc (AQU:PBX)
London · Delayed Price · Currency is GBP · Price in GBX 9.50
0.00 (0.00%)
At close: Aug 11, 2026
ProBiotix Health Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.27 | 1.65 | 1.5 | 1.74 | 0.15 |
Cash & Short-Term Investments | 1.27 | 1.65 | 1.5 | 1.74 | 0.15 |
Cash Growth | -23.09% | 9.59% | -13.68% | 1091.38% | 5.37% |
Accounts Receivable | 0.2 | 0.14 | 0.2 | 0.4 | 0.72 |
Other Receivables | 0.13 | 0.1 | 0.05 | 0.09 | 0.02 |
Receivables | 0.32 | 0.24 | 0.25 | 0.49 | 0.74 |
Inventory | - | 0.03 | 0.1 | 0.05 | 0.01 |
Prepaid Expenses | 0.03 | 0.02 | 0.01 | 0.01 | 0 |
Total Current Assets | 1.62 | 1.93 | 1.87 | 2.29 | 0.9 |
Property, Plant & Equipment | 0.01 | 0.01 | - | - | - |
Other Intangible Assets | 0.19 | 0.24 | 0.3 | 0.36 | 0.35 |
Total Assets | 1.81 | 2.18 | 2.17 | 2.64 | 1.25 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.24 | 0.03 | 0.47 | 0.18 | 0.2 |
Accrued Expenses | 0.07 | 0.06 | 0.07 | 0.08 | 0.05 |
Current Income Taxes Payable | - | 0.01 | - | - | 0 |
Other Current Liabilities | 0.01 | 0.1 | 0.03 | 0.05 | 0.25 |
Total Current Liabilities | 0.32 | 0.19 | 0.57 | 0.31 | 0.5 |
Long-Term Debt | - | - | - | - | 1.08 |
Long-Term Deferred Tax Liabilities | 0.05 | 0.06 | 0.08 | 0.09 | 0.08 |
Total Liabilities | 0.37 | 0.25 | 0.64 | 0.4 | 1.67 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.08 | 0.08 | 0.06 | 0.06 | 0 |
Additional Paid-In Capital | 4.53 | 4.53 | 3.34 | 3.34 | - |
Retained Earnings | -3.02 | -1.79 | -0.98 | -0.23 | -0.54 |
Comprehensive Income & Other | -0.15 | -0.9 | -0.89 | -0.92 | 0.12 |
Shareholders' Equity | 1.44 | 1.92 | 1.53 | 2.25 | -0.42 |
Total Liabilities & Equity | 1.81 | 2.18 | 2.17 | 2.64 | 1.25 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | 1.08 |
Net Cash (Debt) | 1.27 | 1.65 | 1.5 | 1.74 | -0.94 |
Net Cash Growth | -23.09% | 9.59% | -13.68% | - | - |
Net Cash Per Share | 0.01 | 0.01 | 0.01 | 0.02 | -9.38 |
Filing Date Shares Outstanding | 158.17 | 158.17 | 121.67 | 121.67 | 0.1 |
Total Common Shares Outstanding | 158.17 | 158.17 | 121.67 | 121.67 | 0.1 |
Working Capital | 1.3 | 1.74 | 1.31 | 1.98 | 0.4 |
Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.02 | -4.20 |
Tangible Book Value | 1.26 | 1.69 | 1.23 | 1.89 | -0.77 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.02 | -7.66 |
Machinery | 0.01 | 0.01 | - | - | - |